C170 (Darifenacin Hydrobromide Extended-Release 7.5 mg)
Pill with imprint C170 is Yellow, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Par Pharmaceutical, Inc.
Darifenacin is used in the treatment of overactive bladder; urinary frequency; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C170
Darifenacin Hydrobromide Extended-Release
- Imprint
- C170
- Strength
- 7.5 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 10370-0170 (Discontinued)
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
hypromellose 2208 (3 mPa.s),
lactose monohydrate,
magnesium stearate,
polyvinyl alcohol,
magnesium silicate,
polyethylene glycol,
titanium dioxide,
D&C Yellow No. 10,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Related images for "C170"
More about darifenacin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (25)
- Drug images
- Pricing & coupons
- En español
- Drug class: urinary antispasmodics
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.